Combination treatment with radiation and drugs to reduce the risk of death barrier in the men's prostate cancer sufferer. It is disclosed the researchers from Scandinavia on Wednesday, local time.

In the United States, this combination is the standard treatment since the 1990s. However, in Europe, many doctors avoid this combo treatment, and only use the drug because of the use of the hormone simultaneously designate dangerous patients.

"What is shown from this research is that the men, prostate cancer sufferer indeed change means that the aggressive therapy such as this," said Dr. Howard Sandler from Cedars-Sinai Medical Center in Los Angeles.

Around 875 men from various countries such as Denmark, Norway and Sweden, with prostate cancer have been examined more scientists Scandinavia. Half of the men is given hormone drugs resistor, while the rest get radiation plus the same medicine. These drugs work memblokade production testosteron which tend to feed cancer cells.

After nearly nine years, 79 men who only use this hormone drugs commotion died of prostate cancer, 37 other men who use the combo treatment had survived.

"Not enough only to use hormone drugs for patients of this. To get a dramatic increase in repair, you must use radiation. This is a new standard," said Anders Widmark of the University of Umea in Sweden

But, of course, this treatment has side effects. After five years, male recipient of radiation and hormone drugs have reported fatigue, insomnia, and sexual problems. Therefore, although the combination treatment is recommended in the U.S., Sandler said that the treatment does not apply to every patient. They want the combo treatment with this medication must be consultation with the doctor.

"The combination hormone and radiotherapy should now have can be applied universally for patients," said Chris Parker of the Institute of Cancer Research in Surrey, England.

source: kompas

0 komentar:

Posting Lebih Baru Posting Lama Beranda